Kerecis

kerecis.com · Reykjavík, Iceland

Kerecis is a medical technology company that develops and manufactures fish-skin–based tissue regeneration and wound care products used to treat chronic wounds, burns, and surgical defects. Its acellular fish-skin grafts are sold to hospitals, clinics, and healthcare providers, primarily in the U.S. and Europe, through a combination of direct sales and distributor channels. The company generates revenue from product sales and related clinical support services in advanced wound care and reconstructive surgery markets.

Revenue
$50M - $250M
Employees
201 - 1,000
Founded
2009
Headquarters
Reykjavík, Iceland

Kerecis customers on Arbolus

Total customers 12 11 current · 1 former
Reviews growth 9 new reviews since Mar 2026

Customers who reviewed Kerecis

Seniority of Kerecis customers

Most people who reviewed Kerecis hold C-Suite roles (64%), followed by Manager (27%) and Director (9%).

  • C-Suite 64%
  • Manager 27%
  • Director 9%

Customers sample

Not specified Director NPS 9 Will renew
Other Generalist Manager NPS 8
Product Leader Manager NPS 2 Undecided

Employer names and spend open once the report publishes.

What 11 Arbolus experts think of Kerecis

Overall sentiment: Positive

NPS scores cluster in the positive range, with 70% of experts reporting scores of 8 or above, indicating broad promoter support among clinical users. Renewal intent is underreported; among those who responded, there is a notable level of uncertainty, largely from non-clinical influencers. Most users have implemented for more than one year, suggesting good stickiness. Key themes indicate high satisfaction among clinical roles but some emerging hesitancy from influencers.

Tell us when the Kerecis report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Sentiment

0 Net Promoter Score, from 11 scored reviews
  • Promoters 3
  • Passives 5
  • Detractors 3

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 33%
  • Will renew 1
  • Undecided 2
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 0% 1 answer
  • Director 100% 1 answer
  • Manager 0% 1 answer
  • 9/10 Average score from customers who will renew
  • 4/10 Average score from undecided customers

For people who use Kerecis

Do you use Kerecis at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 11 customers of Kerecis have already contributed

Takes a few minutes. Your identity stays anonymous.